Glycopyrrolate Injection
Product Images NDC 70121-1397

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70121-1397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Glycopyrrolate Injection Usp 1)

Chemical structure of glycopyrrolate showing its molecular components including a cyclopentane ring, a phenyl group, ester linkage, and a quaternary ammonium group with bromide ion.*

FDA Label Image

1 (Glycopyrrolate Injection Usp 2)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL, an injection for intramuscular or intravenous use. The label indicates the product contains benzyl alcohol and is supplied as a 1 mL single-dose vial. It is distributed by Amneal Pharmaceuticals LLC and manufactured by G/28/1539 in India. Storage instructions specify 20°C to 25°C (68°F to 77°F).*

FDA Label Image

1 (Glycopyrrolate Injection Usp 3)

Glycopyrrolate Injection, USP 0.2 mg/mL in 25 single-dose 1 mL vials carton by Amneal Pharmaceuticals LLC. Label indicates intramuscular or intravenous use, contains benzyl alcohol, not for use in newborns, and storage at 20° to 25°C. Manufactured by Amneal Pharmaceuticals Pvt. Ltd., India, and distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

FDA Label Image

2 (Glycopyrrolate Injection Usp 4)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) by Amneal Pharmaceuticals LLC. The product contains benzyl alcohol and is for intramuscular or intravenous use. The package is a 2 mL single dose vial. Storage instructions and manufacturer details are also included on the label.*

FDA Label Image

2 (Glycopyrrolate Injection Usp 5)

Glycopyrrolate Injection USP 0.4 mg/2 mL (0.2 mg/mL) label for 25 x 2 mL single dose vials by Amneal Pharmaceuticals LLC. The label states it is for intramuscular or intravenous administration, not for use in newborns, and contains benzyl alcohol. Storage instructions specify 20° to 25°C (68° to 77°F).*

FDA Label Image

1 (Glycopyrrolate Injection Usp 6)

Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) in a 5 mL multiple dose vial. The label states it contains benzyl alcohol and is for intramuscular or intravenous administration. The product is labeled for prescription use only and not for use in newborns. Manufactured and distributed by Amneal Pharmaceuticals LLC.*

FDA Label Image

5 (Glycopyrrolate Injection Usp 7)

Glycopyrrolate Injection USP 1 mg/5 mL (0.2 mg/mL) carton label for injection. Contains benzyl alcohol preservative. For intramuscular or intravenous administration. Not for use in newborns. Package contains 25 multiple dose vials of 5 mL each. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC. Includes storage instructions and barcode.*

FDA Label Image

20 (Glycopyrrolate Injection Usp 8)

Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) injection by Amneal Pharmaceuticals LLC. This multiple dose vial contains benzyl alcohol and is for intramuscular or intravenous administration. Storage instructions specify keeping the vial at 20 to 25°C (68 to 77°F) in a controlled room temperature environment.*

FDA Label Image

20 (Glycopyrrolate Injection Usp 9)

Packaging label for Glycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg/mL) multiple dose vials. The label specifies the injection is for intramuscular or intravenous use, contains benzyl alcohol as a preservative, and is not for use in newborns. The product is manufactured by Amneal Pharmaceuticals Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.